# A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults

> **NCT07692633** · NA · NOT_YET_RECRUITING · sponsor: **Reus Research** · enrollment: 80 (estimated)

## Conditions studied

- NAD+ Bioavailability
- NAD+ Safety
- NAD+ Efficacy

## Interventions

- **DIETARY_SUPPLEMENT:** NAD+
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07692633
- **Lead sponsor:** Reus Research
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692633, "A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*